Literature DB >> 11583174

NMR-detected order in core residues of denatured bovine pancreatic trypsin inhibitor.

E Barbar1, M Hare, M Makokha, G Barany, C Woodward.   

Abstract

The NMR characteristics of [14-38]Abu, a synthetic variant of BPTI that is partially folded in aqueous buffer near neutral pH, support a model of early folding events which begin with stabilization of the nativelike, slow exchange core [Barbar, E., Hare, M., Daragan, V., Barany, G., and Woodward, C. (1998) Biochemistry 37, 7822-7833 (1)]. In partially folded [14-38]Abu, urea denaturation profiles for representative amide protons show that global unfolding is non-two-state and that core residues require a higher concentration of urea to unfold. Dynamic properties of pH-denatured [14-38]Abu and fully reduced and unfolded BPTI analogue were determined from heteronuclear NMR relaxation measurements at similar solution conditions. Differences at various sites in the polypeptide chain were evaluated from spectral density functions determined from T1, T2, and steady-state heteronuclear NOE data. Although denatured [14-38]Abu contains no persistent secondary structure, its most ordered residues are those that, in native BPTI, fold into the slow exchange core. The fully reduced analogue is significantly more mobile and shows less heterogeneous dynamics, but at 1 degree C, restricted motion is observed for residues in the central segments of the polypeptide chain. These observations indicate that there is a developing core or cores even in highly unfolded species. Apparently the effect of 14-38 disulfide on unfolded

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583174     DOI: 10.1021/bi010483z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Close identity of a pressure-stabilized intermediate with a kinetic intermediate in protein folding.

Authors:  Ryo Kitahara; Kazuyuki Akasaka
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

2.  Dynamic transition associated with the thermal denaturation of a small Beta protein.

Authors:  Daniela Russo; Javier Pérez; Jean-Marc Zanotti; Michel Desmadril; Dominique Durand
Journal:  Biophys J       Date:  2002-11       Impact factor: 4.033

3.  The solution structure of the pH-induced monomer of dynein light-chain LC8 from Drosophila.

Authors:  Moses Makokha; Yuanpeng Janet Huang; Gaetano Montelione; Arthur S Edison; Elisar Barbar
Journal:  Protein Sci       Date:  2004-02-06       Impact factor: 6.725

4.  The LC8-RavP ensemble Structure Evinces A Role for LC8 in Regulating Lyssavirus Polymerase Functionality.

Authors:  Nathan E Jespersen; Cedric Leyrat; Francine C Gérard; Jean-Marie Bourhis; Danielle Blondel; Marc Jamin; Elisar Barbar
Journal:  J Mol Biol       Date:  2019-10-18       Impact factor: 5.469

5.  Signal transduction in receptor for advanced glycation end products (RAGE): solution structure of C-terminal rage (ctRAGE) and its binding to mDia1.

Authors:  Vivek Rai; Andres Y Maldonado; David S Burz; Sergey Reverdatto; Shi Fang Yan; Ann Marie Schmidt; Alexander Shekhtman
Journal:  J Biol Chem       Date:  2011-12-21       Impact factor: 5.157

6.  Native state fluctuations in a peroxiredoxin active site match motions needed for catalysis.

Authors:  Aidan B Estelle; Patrick N Reardon; Seth H Pinckney; Leslie B Poole; Elisar Barbar; P Andrew Karplus
Journal:  Structure       Date:  2021-10-21       Impact factor: 5.006

7.  Structural and mechanistic insights into the interaction between Pyk2 and paxillin LD motifs.

Authors:  Murugendra S Vanarotti; Darcie J Miller; Cristina D Guibao; Amanda Nourse; Jie J Zheng
Journal:  J Mol Biol       Date:  2014-08-29       Impact factor: 5.469

8.  SdPI, the first functionally characterized Kunitz-type trypsin inhibitor from scorpion venom.

Authors:  Ruiming Zhao; Hui Dai; Su Qiu; Tian Li; Yawen He; Yibao Ma; Zongyun Chen; Yingliang Wu; Wenxin Li; Zhijian Cao
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.